Allopurinol Tablet shortage
To Be Discontinued 4 presentations · 1 manufacturers · first FDA posting Feb 19, 2026 · last update Feb 19, 2026
Manufacturers: Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Allopurinol, Tablet, 100 mg (NDC 0591-5543-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Feb 19, 2026 Updated Feb 19, 2026 Discontinued Feb 19, 2026 |
| Allopurinol, Tablet, 100 mg (NDC 0591-5543-10) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Feb 19, 2026 Updated Feb 19, 2026 Discontinued Feb 19, 2026 |
| Allopurinol, Tablet, 300 mg (NDC 0591-5544-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Feb 19, 2026 Updated Feb 19, 2026 Discontinued Feb 19, 2026 |
| Allopurinol, Tablet, 300 mg (NDC 0591-5544-05) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Feb 19, 2026 Updated Feb 19, 2026 Discontinued Feb 19, 2026 |